Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ADIAL PHARMACEUTICALS, INC. Director's Dealing 2018

Nov 14, 2018

35331_dirs_2018-11-13_fc05e01f-9db0-40e1-9266-e1860fced583.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ADIAL PHARMACEUTICALS, INC. (ADIL)
CIK: 0001513525
Period of Report: 2018-11-12

Reporting Person: Schuyler Kevin (Director, 10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-11-12 Warrant to purchase units $5.00 J 120000 Disposed 2023-07-31 Units (240000) Direct
2018-11-12 Warrant to purchase common stock $5.00 J 120000 Acquired 2023-07-31 Common Stock (120000) Direct
2018-11-12 Warrant to purchase common stock $6.25 J 120000 Acquired 2023-07-31 Common Stock (120000) Direct
2018-11-12 Warrant to purchase units $5.00 J 162200 Disposed 2023-07-31 Units (324400) Indirect
2018-11-12 Warrant to purchase common stock $5.00 J 162200 Acquired 2023-07-31 Common Stock (162200) Indirect
2018-11-12 Warrant to purchase common stock $6.25 J 162200 Acquired 2023-07-31 Common Stock (162200) Indirect

Footnotes

F1: On November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 120,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 120,000 shares of common stock.

F2: On November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 162,200 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 162,200 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC.